Search Results - "DAOUSSIS, D"

Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus by Mavrogeni, S, Koutsogeorgopoulou, L, Markousis-Mavrogenis, G, Bounas, A, Tektonidou, M, Lliossis, S-N C, Daoussis, D, Plastiras, S, Karabela, G, Stavropoulos, E, Katsifis, G, Vartela, V, Kolovou, G

“…Background Accurate diagnosis of cardiovascular involvement in systemic lupus erythematosus (SLE) remains challenging, due to limitations of echocardiography…”
Get full text

Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort by Panopoulos, S, Chatzidionysiou, Κ, Tektonidou, M G, Bournia, V K, Drosos, A A, Liossis, Stamatis-Nick C, Dimitroulas, T, Sakkas, L, Boumpas, D, Voulgari, P V, Daoussis, D, Thomas, K, Georgiopoulos, G, Vosvotekas, G, Garyfallos, Α, Sidiropoulos, P, Bertsias, G, Vassilopoulos, D, Sfikakis, P P

“…European data indicate that systemic sclerosis (SSc)-related death rates are increasing, thus raising concerns about SSc's optimal management. Herein, we…”
Get full text

Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis by Daoussis, Dimitrios, Liossis, Stamatis-Nick C, Tsamandas, Athanassios C, Kalogeropoulou, Christina, Paliogianni, Fotini, Sirinian, Chaido, Yiannopoulos, Georgios, Andonopoulos, Andrew P

“…To assess the safety and efficacy of long-term treatment with rituximab (RTX) in patients with systemic sclerosis (SSc). Eight patients with SSc-associated…”
Get full text

Outcome of refractory to conventional and/or biologic treatment adult Still's disease following canakinumab treatment: Countrywide data in 50 patients by Laskari, K., Tektonidou, M.G., Katsiari, C., Athanassiou, P., Dimopoulou, D., Gerodimos, C., Salamaliki, C., Papagoras, C., Settas, L., Vassilopoulos, D., Voulgari, P.V., Zakalka, M., Georgiadis, A., Gkoni, G., Daoussis, D., Dimitroulas, T., Iliou, C., Kallitsakis, I., Grika, E.P., Mavragani, C., Pikazis, D., Raftakis, J., Sarikoudis, T., Kougkas, N., Soukera, D., Theodorou, E., Tsatsani, P., Tsiakou, E., Vlachoyiannopoulos, P., Vosvotekas, G., Sfikakis, P.P.

“…To assess the efficacy and safety of the IL-1b inhibitor canakinumab in all adults with refractory Still's disease identified from the National Organization…”
Get full text

Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis by Daoussis, D, Panoulas, V F, Antonopoulos, I, John, H, Toms, T E, Wong, P, Nightingale, P, Douglas, K M J, Kitas, G D

“…The present study aimed to evaluate the prevalence and associations of renal dysfunction in patients with rheumatoid arthritis (RA). It specifically addressed…”
Get more information

Experience with infliximab (anti-TNFα monoclonal antibody) as monotherapy for giant cell arteritis by Andonopoulos, A P, Meimaris, N, Daoussis, D, Bounas, A, Giannopoulos, G

“…[...]we decided to try it in two of our patients with GCA, without concomitant administration of corticosteroids, hoping that if only a few infusions of…”
Get full text

Increased expression of CD154 (CD40L) on stimulated T-cells from patients with psoriatic arthritis by Daoussis, D., Antonopoulos, I., Andonopoulos, A. P., Liossis, S.-N. C.

“…Objectives. CD40L is a costimulatory molecule and an early activation marker of T-lymphocytes. Based on the hypothesis that activated T-cells may play a role…”
Get full text

Investigation of 3D textural features' discriminating ability in diffuse lung disease quantification in MDCT by Mariolis, I, Korfiatis, P, Costaridou, L, Kalogeropoulou, C, Daoussis, D, Petsas, T

“…A current trend in lung CT image analysis is Computer Aided Diagnosis (CAD) schemes aiming at DLD patterns quantification. The majority of such schemes exploit…”
Get full text

PBI20 SECUKINUMAB VS. ADALIMUMAB AND INFLIXIMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: A COST PER RESPONDER ANALYSIS AT 52 WEEKS FROM A GREEK PERSPECTIVE by Daoussis, D., Theofanidis, N., Kalogeropoulou, M.

Get full text

Intra-articular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behçet's disease by Andonopoulos, A P, Meimaris, N, Daoussis, D, Bounas, A, Yiannopoulos, G

Get full text

Infliximab efficiency and failure by Rozin, A P

“…[...]it seems to me that one cannot define GCA as a self limiting disease, unlike polymyalgia rheumatica, as it may have an occult and long term course with a…”
Get full text

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study by Daoussis, Dimitrios, Liossis, Stamatis-Nick C., Tsamandas, Athanassios C., Kalogeropoulou, Christina, Kazantzi, Alexandra, Sirinian, Chaido, Karampetsou, Maria, Yiannopoulos, Georgios, Andonopoulos, Andrew P.

“…Objective. To assess the efficacy of rituximab (RTX) in SSc. Methods. Fourteen patients with SSc were evaluated. Eight patients were randomized to receive two…”
Get full text

ACTH vs betamethasone for the treatment of acute gout in hospitalized patients: A randomized, open label, comparative study by Daoussis, Dimitrios, Kordas, Panagiotis

“…Hospitalized patients usually have significant comorbidities and receive multiple medications which leads to a high frequency of contraindications to standard…”
Get full text

Dickkopf-1 is downregulated early and universally in the skin of patients with systemic sclerosis despite normal circulating levels by Daoussis, Dimitrios, Papachristou, Dionysios J, Dimitroulas, Theodoros, Sidiropoulos, Theodoros, Antonopoulos, Ioannis, Andonopoulos, Andrew P, Liossis, Stamatis-Nick

“…The activity of the Wnt pathway, a critical mediator of fibrosis, is regulated by Dickkopf-1 (Dkk-1). Dkk-1 is absent from scleroderma skin in contrast to skin…”
Get full text

Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective real-life study by Vassilopoulos, Dimitrios, Delicha, Evie M, Settas, Loukas, Andrianakos, Alexandros, Aslanidis, Spyros, Boura, Panagiota, Katsounaros, Marios, Athanassiou, Panagiotis, Tempos, Konstantinos, Skarantavos, Grigorios, Antoniadis, Christodoulos, Papazoglou, Sotirios, Sakkas, Lazaros, Galanopoulou, Vassiliki, Skopouli, Fotini, Boki, Kyriaki, Daoussis, Dimitrios, Vritzali, Eleni, Sfikakis, Petros P

“…To evaluate the long-term safety of rituximab (RTX) in rheumatoid arthritis (RA) patients in daily clinical practice. This was a multicentre (17 Greek…”
Get full text

Uric acid and cardiovascular risk in rheumatoid arthritis by Daoussis, Dimitrios, Kitas, George D.

Get full text

Evolution of undifferentiated arthritis: a ten-year experience from the early arthritis clinic of a tertiary care hospital by Yiannopoulos, Georgios, Daoussis, Dimitrios, Melissaropoulos, Konstantinos, Tsouni, Christina, Andonopoulos, Andrew P

“…Undifferentiated arthritis (UA) is an inflammatory oligo/polyarthritis where no definite diagnosis can be reached. Patients with UA may progress towards a…”
Get full text

Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis: Scleroderma Care and Research 2012 by DAOUSSIS, D, LIOSSIS, S. C, TSAMANDAS, A. C, KALOGEROPOULOU, C, PALIOGIANNI, F, SIRINIAN, C, YIANNOPOULOS, G, ANDONOPOULOS, A. P

Get full text

Evidence that Dkk‐1 is dysfunctional in ankylosing spondylitis by Daoussis, Dimitrios, Liossis, Stamatis‐Nick C., Solomou, Elena E., Tsanaktsi, Anastasia, Bounia, Konstadina, Karampetsou, Maria, Yiannopoulos, Georgios, Andonopoulos, Andrew P.

“…Objective Dkk‐1 is an inhibitory molecule that regulates the Wnt pathway, which controls osteoblastogenesis. This study was undertaken to explore the potential…”
Get full text

Arthritis accompanying ileal pouchitis or undifferentiated HLA B27-related spondyloarthropathy? by YIANNOPOULOS, George, DAOUSSIS, Dimitris, ANDONOPOULOS, Andrew P

“…The case of an HLA B27(+) patient who developed inflammatory arthritis accompanying ileal pouchitis, following total proctocolectomy for familial adenomatous…”
Get full text